Decrease of the DXR-induced genotoxicity and nongenotoxic effects of Theobroma cacao revealed by micronucleus assay

M F G Boriollo1, V E Alves2, T A Silva2

  • 1Laboratório de Genética Molecular, Departamento de Diagnóstico Oral, Faculdade de Odontologia de Piracicaba - FOP, Universidade Estadual de Campinas - UNICAMP, Av. Limeira, 901, Bairro Areião, CEP 13414-903, Piracicaba, SP, Brasil.

Insights

Theobroma cacao Linné seeds extract (TCL) shows no genotoxicity or cytotoxicity in mice. This cacao extract also demonstrated antigenotoxic potential by reducing harmful effects from the chemotherapy drug doxorubicin (DXR).

Area of Science:

  • Toxicology
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Theobroma cacao Linné seeds (TCL) are widely consumed and possess various bioactive compounds.
  • Evaluating the safety and potential therapeutic interactions of natural extracts is crucial.
  • Genotoxicity assessment is vital for understanding the safety profile of any substance.

Purpose of the Study:

  • To evaluate the genotoxicity and cytotoxicity of a lyophilized glycolic extract of Theobroma cacao Linné seeds (TCL) in mice.
  • To investigate the potential antigenotoxic effects of TCL when co-administered with doxorubicin (DXR).

Main Methods:

  • Micronucleus assay in mouse bone marrow was employed to assess genotoxicity.
  • Experimental groups were treated with N-Nitroso-N-ethylurea (NEU), DXR, NaCl, or varying doses of TCL.
  • Antigenotoxic assays involved co-administration of TCL with DXR.

Main Results:

  • TCL did not induce significant genotoxicity or cytotoxicity at any tested dose.
  • DXR and NEU significantly increased micronucleated polychromatic erythrocytes (MNPCEs).
  • TCL administration significantly reduced the MNPCEs induced by DXR, indicating an antigenotoxic effect.

Conclusions:

  • Lyophilized glycolic extract of Theobroma cacao Linné seeds is devoid of genotoxic and cytotoxic properties.
  • TCL exhibits potential antigenotoxic effects, mitigating the genotoxicity induced by doxorubicin.
  • These findings support the safety of TCL and suggest its potential utility in combination therapies.